8
Explore small cap ideas before they hit the headlines.
Explore small cap ideas before they hit the headlines.
AVID will SAVE US
Har har
Arf Arf
Someone take this DOG out back and shoot it.
I know I know
I forgot that at least we will be over a $BUCK$
Oh Happy Days
72 cents
ONLY $4.48 more to my breakeven price.
I sure feel better now.
The FAMILY already owns over 50%
Finally, there can be nefarious motive of misleading the market and manipulating the prices by hiding stocks.
This DOG don't run
Please take it out back and shoot it.
I SEE IT WOOK
Do you see what I see...A bird a bird...Flying in the night...
What did I miss?
Dear Mr King
Please sell this dog.
Please let me go off into the sunset with my 95% loss.
Just Smoke
Great News For The Mice
Now how long before we finish a successful Phase III so we can sell something???
Will we live that long???
Without a profit, there are few alternatives to running a biotech short of equity financing. We seem to have overcome that hurdle with Avid.
Nice business model huh?
During fiscal years 2016, 2015 and 2014, Avid’s total revenue generated from third-party customers amounted to $44,357,000, $26,744,000, and $22,294,000, respectively, of which 69%, 79% and 91%, respectively, was derived from Halozyme Therapeutics, Inc. [color=red][/color]
AVID has nothing to do
with our investment.
We invested in a Bio Tech business, not a Mickey Mouse mfg firm for OTHER successful businesses.
We need the RS solely because there is no other way we can sell 50% PLUS of our company to a buyer the Mgt wants.
You have found the key to our future.
Mgt knows exactly who owns all of our shares.
They know they don't enough left on the shelf to sell out a majority of the stock to buyer they want.
The reverse split will solve that problem.
We will have a new owner and yes, most our BOD will be gone or become lackeys for new owner.
There is a simple fact....without BIG BUCKS going to R&D we will never get a successful Phase III.
We have no money now and certainly a RS will not provide us with squat for R&D.
Hostile takeovers/buyouts happen more and more these days and what is the value of PS Targeting patents if Immunotherapy becomes a $200Billion industry per year within 5 years? Now imagine PS Targeting having a percent of that $200 Billion figure... Hmmmm
Blackrock
Total sold 8,711,582
I am glad you made this letter because I was asked to make one and couldn't.
One side of the story
Now we look forward to CP's response.
Peregrine Pharmaceuticals..... who is behind all the manipulation?
Maybe we get our answer Soon.
Avid is in the hands of Halozyme. They fail or decide to leave, Avid is cooked. Not a great position to be in.
The reality of Avid
A clear accurate summary of reality.
Thank you for the post and analysis.
Wise purchase.
You should easily make a 50% profit in 6 months.
$.41 ????
You really messed up on your purchase price however..
I'm sure if you played your cards right you could have
bought at $.4067
Look at all the money you flushed down the ........
Furthermore I would emphasise that that one big customer has orders scheduled into 2017 of which that one big customer cannot just back-out without consequences.
Read again Buddy.
Give us a forecast.
Thanks for the Avid financials.
I'm also interested in the forecasts for Avid IV & V.
Any help you can give us with projections would be appreciated.
My TDAmeritrade shows 10 shares at the ask of .3997. I've never seen less than 100 shares before. Anyone explain?
Now 100K pops up next at .40 ask but 10 shares at .3997 is still there.
As I am not into easy one-liners I will develop the reasoning some more giving you more material to either acknowledge or challenge because I can of course be wrong.
Who will it be
I just don't understand the head count no being reduced due to the failed trial.
pembrolizumab is from MERCK and durvalumab from AZN. You switched them.
And don't give me this nonsense about how much Avid is worth. The market knows that all profits raised by Avid will be used to line the pockets of the BOD.
The Family still owns the shares.
Yes they have evaded the 5% rule. It was easy.
When it comes to potential billions of dollars there are no rules that are not meant to be broken.
And yes the Family is still active in manipulating our stock price.
They are masters of 4 decimal place buying and selling among themselves.
The Family is alive and well.....at the present time Bavi is no threat to their 1% status in the world.
If Bavi ever becomes a commercial success the Family will win regardless if their BP benefactor gains control of PPHM.
The world has a specific order and that is the 1% stays in the 1% and the rest of us hope for a few crumbs.
They could also change back to doing IIs and IIIs once and if revenues from Avid go crazy higher.
Sounds like there will be several small open label I-O combo P1 trials producing patient data across a few different cancer indications. Certainly they'll be much faster than large P2 and P3 trials.
AVID and my pain.
AVID is and was meant to be the in house mfg of Bavi for commercial sales and research.
AVID by bad luck has excess capacity which is being used for some expense reductions.
AVID as far as making PPHM successful and a good stock purchase
DOES NOT MEAN SQUAT
What concerns me is
we have had ONE Phase III go to the end.
It was unsuccessful.
We have nothing to SELL.
We are 5 plus years from another Phase III being completed.
We have nothing to SELL.
No sales, no great PPS increase.
No great PPS increase means my gamble failed.
Hi Ho Hi Ho off to work I go.
PYRITE it's PYRITE
You just have to LOVE those Lurkers
I need you in my poker games
Quote:
--------------------------------------------------------------------------------
If PPHM does a REVERSE SPLIT and the SHELF REMAINS (=is not split) then BP knows they will NEVER STOP them again because PPHM will pre-fund and then AstraZeneca will be the game-breaker with Durvalumab
--------------------------------------------------------------------------------